Durvalumab

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

5 monthes ago   |   Xconomy   |   2 articles

The treatment landscape for lung cancer has shifted significantly over the past few years , and more changes could be on the way. At the World Conference on Lung Cancer in...
Read more ...

Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting

One year ago   |   San Diego Biotechnology   |   3 articles

SAN DIEGO, Nov. 9, 2018 /PRNewswire/ - Mirati Therapeutics, Inc. , a clinical-stage targeted oncology company, announced data from the ongoing Phase 2 clinical trial of...
Read more ...

Phase 1b/2 Data of Durvalumab Plus Danvatirsen Presented at European Society for Medical Oncology

One year ago   |   San Diego Biotechnology   |   2 articles

Response rate approximately doubled compared to previous studies with durvalumab alone in refractory head and neck cancerDanvatirsen, Ionis' most advanced Generation 2.5...
Read more ...

Bio Roundup: CRISPR Tests, Parkinson's Questions, Opioid Bills & More

Bio Roundup: CRISPR Tests, Parkinson's Questions, Opioid Bills & More

One year ago   |   Xconomy

Politics is more partisan than ever these days, but the opioid crisis might be one of the few issues where elected officials find common ground. This week, members of Congress...
Read more ...

Incyte, Merck Cancer Trial Failure Damages IDO Drugs' Prospects

Incyte, Merck Cancer Trial Failure Damages IDO Drugs' Prospects

One year ago   |   Xconomy

A late-stage clinical trial testing the combination of a Merck cancer treatment and a new type of cancer drug developed by Incyte has failed , dealing a blow to a new drug...
Read more ...

Tempest Therapeutics Debuts with $70M to Bring Cancer Drugs to Clinic

Tempest Therapeutics Debuts with $70M to Bring Cancer Drugs to Clinic

One year ago   |   Xconomy

A number of companies are trying to improve cancer immunotherapy by disrupting the ways that tumors evade the immune system. Tempest Therapeutics is now joining that group with...
Read more ...

Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More

Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More

One year ago   |   Xconomy

Drug prices are top of mind for many patients. Some of them have to cut back on basic needs just to pay for treatments that seem to rise in price each year. That made a recent...
Read more ...

Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More

Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More

2 years ago   |   Xconomy

The 2018 Winter Olympics will end soon, and we did not skate through these games without a performance-enhancing drug allegation rearing its ugly head. This time, the drug in...
Read more ...

Merck Is Latest to Tout Success as Lung Cancer Drug Combos Plow Forward

Merck Is Latest to Tout Success as Lung Cancer Drug Combos Plow Forward

2 years ago   |   Xconomy

This morning has brought another positive development in the rapidly changing treatment landscape for lung cancer. Merck reported that a combination regimen utilizing its...
Read more ...

Mirati Therapeutics' Mocetinostat Included In Stand Up To Cancer's Cutting-Edge Clinical Trial Initiative For NSCLC Patients

2 years ago   |   San Diego Biotechnology

· Clinical trial combining mocetinostat with pembrolizumab and guadecitabine in NSCLC now open and enrolling patients· Enrollment continues in Mirati-sponsored clinical trial...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...

A deep dive into cellular aging

Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus -a nd identified an... Read more ...